| Literature DB >> 25298754 |
Anna Skarpańska-Stejnborn1, Piotr Basta2, Justyna Sadowska3, Lucja Pilaczyńska-Szcześniak4.
Abstract
BACKGROUND: The aim of this study was to analyze the effect of supplementation with chokeberry (Aronia melanocarpa) juice on the levels of pro-inflammatory cytokines, hepcidin, and selected markers of iron metabolism in rowers subjected to exhaustive exercise.Entities:
Keywords: Chokeberry; Exercise; Interleukin; Iron; Rowers; Supplementation
Year: 2014 PMID: 25298754 PMCID: PMC4189731 DOI: 10.1186/s12970-014-0048-5
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Basic characteristics of the studied groups (mean ± standard deviation)
|
|
|
|
|---|---|---|
| Age (years) | 20.5 ± 0.97 | 20.8 ± 1.09 |
| Body mass (kg) | 86.7 ± 1.72 | 90.2 ± 12.11 |
| Body height (cm) | 188.5 ± 1.71 | 195.8 ± 8.07 |
| Duration of training (years) | 5.4 ± 1.1 | 5.7 ± 1.7 |
P = NS for all between-group comparisons.
Training schedules during the weeks preceding blood sample collections before (Trial 1) and after (Trial 2) the supplementation period
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| Total training time, min/day | 200 | 110 | 210 | 120 | 190 | 110 | 80 |
| Time rowed, min/day | 80 | 90 | 110 | 100 | 75 | 90 | |
| Distance rowed, km/day | 18 | 20 | 24 | 22 | 18 | 20 | |
| Training for force development, min/day | 80 | 80 | 85 | ||||
| Extensive endurance rowing training time, min/day | 80 | 60 | 90 | 100 | 30 | 60 | |
| High intensity endurance rowing training time, min/day | 30 | 20 | 45 | 30 | |||
| Unspecific training (running, etc.), min/day | 40 | 10 | 20 | 20 | 30 | 20 | 80 |
|
| |||||||
|
|
|
|
|
|
|
| |
| Total training time, min/day | 90 | 220 | 110 | 170 | 190 | 100 | |
| Time rowed, min/day | 80 | 130 | 100 | 150 | 110 | 80 | |
| Distance rowed, km/day | 16 | 26 | 22 | 30 | 24 | 18 | |
| Training for force development, min/day | 70 | 60 | |||||
| Extensive endurance rowing training time, min/day | 60 | 75 | 100 | 95 | 80 | 60 | |
| High intensity endurance rowing training time, min/day | 55 | 65 | 20 | 20 | |||
| Unspecific training (running, etc.), min/day | 10 | 20 | 10 | 20 | 20 | 20 | |
Content levels of phenolic compounds in extracts from black chokeberry
|
|
|
|---|---|
|
| 2181.05 ± 48.32 |
|
| 498.80 ± 8.84 |
|
| 53.85 ± 0.50 |
|
| 15.09 ± 0.14 |
|
| 117.60 ± 1.45 |
Basic chromatographic parameters
|
| |
|---|---|
|
| |
|
| |
|
|
|
| 0 | 0 |
| 22 | 80 |
| 26 | 80 |
| 28 | 0 |
| 31 | 0 |
| Flow rate 1.1 mL x min-1 | |
Changes in 2,000 m rowing ergometer performance before and after supplementation
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Power (watt) | 441 ± 30.8 | 443 ± 34.9 | 437 ± 35.9 | 444 ± 38.5 |
| (W x kg-1) | 5.11 ± 0.23 | 5.13 ± 0.24 | 4.88 ± 0.31 | 4.94 ± 0.29 |
| LAmin (mmol x L-1)a | 1.9 ± 0.16 | 1.8 ± 0.43 | 1.9 ± 0.12 | 1.9 ± 0.35 |
| LAmax (mmol x L-1)a | 15.2 ± 2.62 | 15.8 ± 2.09 | 14.6 ± 2.30 | 14.8 ± 3.67 |
| Time (s) | 370.4 ± 9.58 | 369.5 ± 10.44 | 373.8 ± 15.84 | 371.2 ± 10.33 |
Values represent the mean ± standard deviation. aLA, lactic acid. There were no significant differences after supplementation relative to before supplementation (P < 0.05).
Figure 1Changes in interleukin 6 (A) and tumor necrosis factor alpha (B) levels during exercise tests performed before and after the supplementation (mean ± ). Note: IL-6 = interleukin 6; TNF α = tumor necrosis factor alpha; (gray square) - PLA = placebo group; □ - SUPL = supplemented group; *P < .05 compared to the placebo group; † P < .05 compared to the pre-exercise values. ‡ P < .05 compared to the pre-supplementation values.
Figure 2Changes in the total antioxidant capacity (A) and uric acid (B) levels during exercise tests performed before and after the supplementation (mean ± ). Note: TAC = total antioxidant capacity; UA = uric acid; (gray square) - PLA = placebo group; □ - SUPL = supplemented group; *P < .05 compared to the placebo group; † P < .05 compared to the pre-exercise values; ǂ P < .05 compared to the post-exercise values; ‡ P < .05 compared to the pre-supplementation values.
Figure 3Changes in hepcidin (A) and serum iron (B) levels during exercise tests performed before and after the supplementation (mean ± ). Note: Fe = iron; (gray square) - PLA = placebo group; □ - SUPL = supplemented group; * P < .05 compared to the placebo group; † P < .05 compared to the pre-exercise values; ‡ P < .05 compared to the pre-supplementation values.
Changes in iron metabolism during exhaustive exercise before and after supplementation
|
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||
| Myoglobin (ng x mL-1) | 0.0129 | 0.835 | 0.982 | ||||||
| SUPL | 203 ± 63.8 | 346 ± 169.5* | 230 ± 68.6 | 228 ± 168.7 | 405 ± 283.5 | 300 ± 110.5 | |||
| PLA | 216 ± 21.0 | 318 ± 109.4* | 201 ± 39.6 | 267 ± 192.5 | 409 ± 340.2 | 348 ± 233.4 | |||
| Ferritin (ng x dL-1) | 0.062 | 0.083 | 0.069 | ||||||
| SUPL | 74.25 ± 51.18 | 71.22 ± 29.23 | 80.00 ± 52.15 | 80.87 ± 31.02 | 89.67 ± 33.14 | 82.44 ± 28.54 | |||
| PLA | 87.80 ± 27.25 | 91.00 ± 32.34 | 87.20 ± 18.58 | 76.80 ± 24.27 | 84.00 ± 33.35 | 77.80 ± 19.25 | |||
| TIBC (ug x dL-1) | 0.087 | 0.865 | 0.076 | ||||||
| SUPL | 320.8 ±32.83 | 334.2 ± 34.57 | 325.2 ± 26.82 | 326.8 ±52.63 | 339.2 ± 24.37 | 320.5 ± 31.72 | |||
| PLA | 316.7 ± 26.36 | 331.4 ± 25.97 | 328.3 ± 24.3 | 330.4 ± 48.3 | 349.5 ± 48.3 | 329.8 ± 40.6 | |||
| UIBC (ug x dL-1) | 0.498 | 0.693 | 0.735 | ||||||
| SUPL | 175.0 ± 17.92 | 189.3 ± 18.87 | 177.6 ± 14.66 | 183.5 ± 39.72 | 194.6 ± 54.87 | 179.7 ± 38.95 | |||
| PLA | 179.3 ± 11.62 | 192.3 ± 28.41 | 173.4 ± 15.54 | 190.1 ± 43.34 | 198.3 ± 49.73 | 188.43 ± 43.65 | |||
The values represent the mean ±SD. Abbreviations: TIBC total iron-binding capacity, UIBC unsaturated iron-binding capacity, PLA placebo group, SUPL supplemented group; * P < 0.05 relative to pre-exercise - post-exercise.